Could New Ebola Treatments Bring Hope to Congo?
Health officials in the Democratic Republic of the Congo are celebrating the results of a clinical trial that saw two drugs ensure the survival of 90 percent of patients who’d contracted the disease shortly before treatment. The first therapy, REGN-EB3, is made from cloning three separate Ebola antibodies; the second, known as mAb114, was developed by cloning a single antibody from a person infected in 1995.
How many people are at risk? In 12 months, Ebola has killed nearly 1,900 of the more than 2,800 people infected in the DRC, which is why one trial investigator hails the potential treatments as “really good news.”
Don’t miss this OZY feature about Nigeria’s doctor drain.